Whan In Pharm Co.,Ltd. (016580.KS) KSC

Currency In KRW

AD

Valuation

Market Cap210.55B
Enterprise Value147.65B
P/E Ratio10.53
PEG Ratio-0.38
Price/Sales Ratio0.56
Price/Book Ratio0.43
Enterprise/Revenue0.34
Enterprise/EBITDA3.58

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue255.21B
Revenue/Share14,311.35
Gross Profit106.65B
EBITDA24.07B
Net Income13.6B
Diluted EPS857

Balance Sheet

Total Cash63.39B
Total Cash/Share3,408.17
Total Debt579.15M
Total Debt/Equity0
Current Ratio4.1
Book Value Per Share22,803.36

Price History

52-Week Change-18.25
52-Week High13,210
52-Week Low9,670
Moving Average 50 Days10,756.4
Moving Average 200 Days10,877.48

Statistics

Average Volume52,732
Shares Outstanding15.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate300
Trailing Annual Dividend Yield3.09
Payout Ratio0.29
Last Split Factor2:1
Last Split DateApril 14, 2010
AD